These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 22406696)

  • 1. Targeting endothelin receptors for pharmacotherapy of ischemic stroke: current scenario and future perspectives.
    Kaundal RK; Deshpande TA; Gulati A; Sharma SS
    Drug Discov Today; 2012 Jul; 17(13-14):793-804. PubMed ID: 22406696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current therapies in ischemic stroke. Part B. Future candidates in stroke therapy and experimental studies.
    Broussalis E; Trinka E; Killer M; Harrer A; McCoy M; Kraus J
    Drug Discov Today; 2012 Jul; 17(13-14):671-84. PubMed ID: 22405898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of combination of endothelin receptor antagonist (TAK-044) and aspirin in middle cerebral artery occlusion model of acute ischemic stroke in rats.
    Briyal S; Gulati A; Gupta YK
    Methods Find Exp Clin Pharmacol; 2007 May; 29(4):257-63. PubMed ID: 17609737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In vivo exploration of cerebral ischemia: use of neuroprotective agents in animal studies].
    Lestage P; Lockhart B; Roger A
    Therapie; 2002; 57(6):554-63. PubMed ID: 12666263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioids modulate post-ischemic progression in a rat model of stroke.
    Kao TK; Ou YC; Liao SL; Chen WY; Wang CC; Chen SY; Chiang AN; Chen CJ
    Neurochem Int; 2008 May; 52(6):1256-65. PubMed ID: 18294735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ischemic stroke intervention requires mixed cellular protection of the penumbra.
    Barone FC
    Curr Opin Investig Drugs; 2009 Mar; 10(3):220-3. PubMed ID: 19333878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Injury and repair mechanisms in ischemic stroke: considerations for the development of novel neurotherapeutics.
    Candelario-Jalil E
    Curr Opin Investig Drugs; 2009 Jul; 10(7):644-54. PubMed ID: 19579170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection.
    Legos JJ; Lenhard SC; Haimbach RE; Schaeffer TR; Bentley RG; McVey MJ; Chandra S; Irving EA; Andrew A Parsons ; Barone FC
    Exp Neurol; 2008 Jul; 212(1):53-62. PubMed ID: 18462720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The endothelin receptor antagonist SB 217242 reduces cerebral focal ischemic brain injury.
    Barone FC; White RF; Elliott JD; Feuerstein GZ; Ohlstein EH
    J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S404-7. PubMed ID: 8587428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelins-1/3 and endothelin-A/B receptors expressing glial cells with special reference to activated microglia in experimentally induced cerebral ischemia in the adult rats.
    Li JJ; Wu LH; Cao Q; Yuan Y; Yang L; Guo ZY; Kaur C; Sivakumar V; Ling EA; Wu CY
    Neuroscience; 2010 May; 167(3):665-77. PubMed ID: 20206236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombolysis and neuroprotection in cerebral ischemia.
    Gutiérrez M; Díez Tejedor E; Alonso de Leciñana M; Fuentes B; Carceller F; Roda JM
    Cerebrovasc Dis; 2006; 21 Suppl 2():118-26. PubMed ID: 16651822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post stroke intervention: is the window widening?
    Zhan X; Kuczynski B; Sharp FR
    Neuropharmacology; 2011 May; 60(6):1000-2. PubMed ID: 21315742
    [No Abstract]   [Full Text] [Related]  

  • 13. Neuroprotective agents in Acute Ischemic Stroke-A Reality Check.
    Goenka L; Uppugunduri Satyanarayana CR; S SK; George M
    Biomed Pharmacother; 2019 Jan; 109():2539-2547. PubMed ID: 30551514
    [No Abstract]   [Full Text] [Related]  

  • 14. The neuroprotective role of the brain opioid system in stroke injury.
    Vaidya B; Sifat AE; Karamyan VT; Abbruscato TJ
    Drug Discov Today; 2018 Jul; 23(7):1385-1395. PubMed ID: 29501910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recanalization and reperfusion therapies for acute ischemic stroke.
    Molina CA; Alvarez-Sabín J
    Cerebrovasc Dis; 2009; 27 Suppl 1():162-7. PubMed ID: 19342847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotective profile of novel SRC kinase inhibitors in rodent models of cerebral ischemia.
    Liang S; Pong K; Gonzales C; Chen Y; Ling HP; Mark RJ; Boschelli F; Boschelli DH; Ye F; Barrios Sosa AC; Mansour TS; Frost P; Wood A; Pangalos MN; Zaleska MM
    J Pharmacol Exp Ther; 2009 Dec; 331(3):827-35. PubMed ID: 19741150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Animal models of cerebral ischemia for evaluation of drugs.
    Gupta YK; Briyal S
    Indian J Physiol Pharmacol; 2004 Oct; 48(4):379-94. PubMed ID: 15907047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repeated administration of exendin-4 reduces focal cerebral ischemia-induced infarction in rats.
    Briyal S; Gulati K; Gulati A
    Brain Res; 2012 Jan; 1427():23-34. PubMed ID: 22055454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythropoietin in stroke: quo vadis.
    Digicaylioglu M
    Expert Opin Biol Ther; 2010 Jun; 10(6):937-49. PubMed ID: 20394473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective drug development in stroke: blood pressure and its impact.
    McCulloch J
    J Hypertens Suppl; 1996 Dec; 14(5):S131-8. PubMed ID: 9120670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.